Nightingale Health Oyj (NHLTY) Q4 2026 Earnings Call Transcript

Nightingale Health Oyj ( NHLTY ) Q4 2026 Earnings Call September 16, 2026 7:00 AM EDT Company Participants Teemu Suna - Founder, Interim CFO, CEO & Director Janna Ranta - COO and Chief Commercial Officer of Research & Healthcare Presentation Teemu Suna Founder, Interim CFO, CEO & Director Good afternoon, and welcome to the Nightingale Health Financial Year '25-'26 webcast. My name is Teemu Suna. I'm CEO and Founder of Nightingale Health. I'm currently also CFO of the company. Today, our agenda is I will first talk about Nightingale Health. Then we will go to the business targets of the past fiscal year. Then we look into the business targets of the current fiscal year. Then we'll have a business update. I go through the different business areas. Then we will have the financial review, then we look at the AGM and financial calendar. Then we have some significant events after the end of the period. And then in the end, we have Q&A, and you can post your questions. We will go them through in the Q&A in the end. So let's start. So Nightingale Health, we are a global health technology company. We've been building the company for more than 10 years. We have a global footprint. We run our own laboratories in the U.S., U.K., Finland, Japan, Singapore. We work in B2B and B2G markets and the main focus is preventive health care. So what Nightingale is all about. We have created a preventive health care platform. And this is a preventive health care platform that enables various AI-powered applications. So the problem with basically all health care applications today is that there is no globally standardized clinical grade way to measure health trajectories and intervention impact. So we actually take actions in health care, but we don't know what is the impact of those actions. We operate